08 Oct, 2025 Bharat School of Pharmacy Hyderabad TS PGECET Cutoff 2025 has been released. Check round-wise Bharat School of Pharmacy Hyderabad TS PGECET Cutoff 2025.
Course | Fees | Eligibility | Application Date | Action |
---|---|---|---|---|
₹1.07 Lakhs (1st Year Fees) | Post Graduation | 1 Mar - 04 Apr 2025 | ||
₹2.04 Lakhs (Total Fees) | B.Pharm | - | ||
₹60,000 (1st Year Fees) | 10+2 with 45% + TS EAMCET | 28 June - 09 Sept 2025 | ||
₹60,000 (1st Year Fees) | D.Pharm with 45% + TS ECET | 18 July - 19 Jul 2025 | ||
M.Pharm 2 Courses | ₹2.72 Lakhs (Total Fees) | B.Pharm. with 50% + TS PGECET | 1 Aug - 18 Aug 2025 |
Do you think the Course details are wrong ? Report Here
Select Degree and Streams to See Course Fees and Admission Details.
Eligibility:
Application Date:
Eligibility:
Eligibility:
Application Date:
Eligibility:
Application Date:
Eligibility:
Application Date:
Do you think the fees are wrong ? Report Here
Events | Dates |
---|---|
Counselling & Allotment Issuance for Kashmiri Migrants TG EAPCET Admission [B.Pharm] | Sep 11, 2025 |
Online Application for Kashmiri Migrants TG EAPCET Admission [B.Pharm] | Sep 09, 2025 |
Admission Timeline [B.Pharm] | Jun 28, 2025 - Sep 09, 2025 |
Do you think the Dates are wrong ? Report Here
Search from 20K+ Courses and 35+ Streams
Likes
Dislikes
Likes
Dislikes
Likes
Dislikes
Do you think the data is wrong ? Report Here
You can check here to see what types of facilities Bharat School of Pharmacy Hyderabad provides.
Basic Information about the Faculty of Bharat School of Pharmacy Hyderabad
Scholarship provided by college
Basic Information About the Colleges
Comments
Found 2 Comments
Yes, there is a concession in fees as per the category norms of the government. It also offers fee concession to students holding merit by giving them scholarships.
The percentage of the students got placed are above 40% and the major companies that visited the campus are above 60. There is no information regarding the highest CTC. Please get in touch with the college for more information on this.